| Donna Buckland Gallen, OTR | |
|
11960 Westline Industrial Dr, Suite 201, Saint Louis, MO 63146-3209 | |
| (314) 819-0480 | |
| (314) 275-7444 |
| Full Name | Donna Buckland Gallen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 11960 Westline Industrial Dr, Saint Louis, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013378694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2001026834 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donna Buckland Gallen, OTR 15739 Heathercroft Dr, Chesterfield, MO 63017-8706 Ph: (314) 374-7572 | Donna Buckland Gallen, OTR 11960 Westline Industrial Dr, Suite 201, Saint Louis, MO 63146-3209 Ph: (314) 819-0480 |
News Archive
Earlier this month, Dr. Rashid Buttar posted on Twitter that covid-19 "was a planned operation" and shared an article alleging that most people who got the covid vaccine would be dead by 2025.
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years. These molecular sites appear to result in some level of immunity to the new virus in people who were exposed to the earlier influenza viruses.
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
New research published this week in Nature has found several drugs could lead to new treatment options for multiple sclerosis (MS), including two drugs that effectively treat MS at the source, in vivo. When administered at the peak of disease, these two drugs showed a striking reversal of disease severity.
› Verified 9 days ago
Michelle Lauren Chambers, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6022 S Lindbergh Blvd Ste 100, Saint Louis, MO 63123 Phone: 314-845-7751 Fax: 314-845-7752 | |
Miss Kaitlin Marie Chilman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3625 Magnolia Ave, Saint Louis, MO 63110 Phone: 618-841-7444 | |
Hannah Florence, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4471 Olive St, Saint Louis, MO 63108 Phone: 314-531-0982 | |
Emily Ruyle, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2718 Sutton Blvd, Saint Louis, MO 63143 Phone: 314-246-0751 Fax: 314-754-9926 | |
Kathleen Sayler, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10950 Coral Ridge Dr, Saint Louis, MO 63123 Phone: 314-724-3770 | |
Jennifer Ewald, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12110 Clayton Rd, Saint Louis, MO 63131 Phone: 314-989-8150 | |
Mrs. Jodie Rae Pohl, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12120 Conway Rd, Saint Louis, MO 63141 Phone: 314-251-7563 |